Effects of Meditation and Yoga on A...

AI Summary

This randomized clinical trial examined the effects of meditation and yoga practices on Parkinson's disease patients, offering insights relevant to Non-Sleep Deep Rest (NSDR) approaches. Researchers studied 159 participants with idiopathic Parkinson's disease across three groups: meditation (n=53), yoga (n=52), and usual care control (n=54). Both interventions were delivered in 90-minute group sessions for 8 weeks. The study suggests that mindfulness-based practices similar to NSDR protocols may provide significant benefits for neurological health. Both meditation and yoga groups showed improvements in anxiety symptoms, motor function, health-related quality of life, and mindfulness skills at 2 months, with sustained reductions in inflammatory markers (interleukin-6) at 6 months. Notably, meditation provided additional benefits including reduced depressive symptoms and longer-lasting improvements in motor function and quality of life. These findings suggest that NSDR-type practices may support neurological health through multiple pathways, including reduced inflammation and improved psychological well-being, though this study focused specifically on Parkinson's patients rather than healthy individuals.

Key Findings

Both meditation and yoga significantly reduced anxiety symptoms, motor symptoms, and improved health-related quality of life in Parkinson's patients at 2 months

Both practices led to significant reductions in serum interleukin-6 levels (a marker of chronic inflammation) at 6 months

Meditation provided unique benefits in reducing depressive symptoms and sustaining motor and quality of life improvements longer than yoga

Both interventions improved mindfulness describing skills, suggesting enhanced self-awareness and cognitive benefits

Abstract

Clinical guidelines recommend a holistic approach to Parkinson's disease (PD) care, yet randomized trials examining mindfulness-based interventions in this context are scarce. This study investigated the effects of two mindfulness practices - meditation and yoga - on biopsychosocial outcomes in PD patients, including anxiety symptoms, depressive symptoms, motor/nonmotor symptoms, health-related quality-of-life (HRQOL), mindfulness, and stress and inflammation biomarkers, compared to usual care. 159 participants with a clinical diagnosis of idiopathic PD and a Hoehn and Yahr stage of 1, 2, and 3, were randomized into meditation (n = 53), yoga (n = 52), and control (n = 54). Meditation and yoga were delivered in 90-min groups for 8 weeks. Primary outcomes included anxiety symptoms and depressive symptoms. Secondary outcomes included motor and nonmotor symptoms, HRQOL, mindfulness, and serum levels of interleukin-6, cortisol and TNF-alpha. Assessments were done at baseline (T0), 2 months (T1), and 6 months (T2). Linear mixed models were conducted following intention-to-treat principle. Compared to control, both meditation, and yoga groups had significant improvements in anxiety symptoms (meditation: mean difference [MD] = -1.36, 95% CI: -2.46 to-0.26; yoga: MD = -1.61, CI: -2.70 to -0.52), motor symptoms (meditation: MD = -5.35, CI: -8.61 to-2.09; yoga: MD = -6.59, CI: -9.82 to-3.36), HRQOL (meditation: MD = -2.01, CI: -3.41 to-0.62; yoga: MD = -1.45, CI: -2.83 to-0.08), and describing skills (meditation: MD = 0.97, CI: 0.04-1.89; yoga: MD = 0.92, CI: 0.01-1.84) at T1, and significant reductions in serum interleukin-6 levels (meditation: MD = -1.14, CI: -2.18 to-0.10; yoga: MD = -1.11, CI: -2.09 to-0.13) at T2. Only meditation significantly reduced depression (MD = -1.44, CI: -2.57 to-0.30) at T1 and sustained the motor and HRQOL improvements at T2. Meditation and yoga significantly improved anxiety symptoms, chronic inflammation, motor symptoms, mindfulness-describing facet, and HRQOL in PD patients. Meditation provided additional benefits in reducing depressive symptoms and sustaining motor and HRQOL improvements. Clinical guidelines recommend a holistic approach to Parkinson's disease (PD) care, yet randomized trials examining mindfulness-based interventions in this context are scarce. This study investigated the effects of two mindfulness practices - meditation and yoga - on biopsychosocial outcomes in PD patients, including anxiety symptoms, depressive symptoms, motor/nonmotor symptoms, health-related quality-of-life (HRQOL), mindfulness, and stress and inflammation biomarkers, compared to usual care. 159 participants with a clinical diagnosis of idiopathic PD and a Hoehn and Yahr stage of 1, 2, and 3, were randomized into meditation (n = 53), yoga (n = 52), and control (n = 54). Meditation and yoga were delivered in 90-min groups for 8 weeks. Primary outcomes included anxiety symptoms and depressive symptoms. Secondary outcomes included motor and nonmotor symptoms, HRQOL, mindfulness, and serum levels of interleukin-6, cortisol and TNF-alpha. Assessments were done at baseline (T0), 2 months (T1), and 6 months (T2). Linear mixed models were conducted following intention-to-treat principle. Compared to control, both meditation, and yoga groups had significant improvements in anxiety symptoms (meditation: mean difference [MD] = -1.36, 95% CI: -2.46 to-0.26; yoga: MD = -1.61, CI: -2.70 to -0.52), motor symptoms (meditation: MD = -5.35, CI: -8.61 to-2.09; yoga: MD = -6.59, CI: -9.82 to-3.36), HRQOL (meditation: MD = -2.01, CI: -3.41 to-0.62; yoga: MD = -1.45, CI: -2.83 to-0.08), and describing skills (meditation: MD = 0.97, CI: 0.04-1.89; yoga: MD = 0.92, CI: 0.01-1.84) at T1, and significant reductions in serum interleukin-6 levels (meditation: MD = -1.14, CI: -2.18 to-0.10; yoga: MD = -1.11, CI: -2.09 to-0.13) at T2. Only meditation significantly reduced depression (MD = -1.44, CI: -2.57 to-0.30) at T1 and sustained the motor and HRQOL improvements at T2. Meditation and yoga significantly improved anxiety symptoms, chronic inflammation, motor symptoms, mindfulness-describing facet, and HRQOL in PD patients. Meditation provided additional benefits in reducing depressive symptoms and sustaining motor and HRQOL improvements.

Related Research

Neurodegenerative

Sleep physiology, pathophysiology, and sleep hygiene.

Progress in cardiovascular diseasesJan 2023

AI Summary

This comprehensive review examines sleep's fundamental role in health optimization and provides evidence-based recommendations for improving sleep quality. The researchers highlight that quality sleep supports multiple biological functions including cardiovascular health, mental health, cognition, memory consolidation, immunity, reproductive health, and hormone regulation. The study identifies common sleep problems including insomnia, sleep apnea, and circadian rhythm disorders that can contribute to significant health issues. The authors emphasize that proper sleep hygiene through behavioral modifications represents the most effective long-term approach to sleep improvement. They provide specific recommendations including maintaining 7-9 hours of sleep, consistent sleep/wake schedules, regular bedtime routines, exercise, and contemplative practices. The review also identifies substances and behaviors that negatively impact sleep quality, including late-day caffeine, alcohol, heavy meals, and light exposure, which are associated with fragmented, poor-quality sleep. This research directly supports Blueprint Sleep Optimization by providing evidence-based strategies for enhancing sleep duration and quality.

Neurodegenerative

The effects of light therapy on sleep problems: A systematic review and meta-analysis.

Sleep medicine reviewsOct 2016

AI Summary

This systematic review and meta-analysis examined the effectiveness of light therapy for various sleep problems, analyzing 53 studies with 1,154 participants total. The research found that light therapy demonstrates moderate effectiveness for treating sleep problems generally, with small to medium effect sizes. The study suggests light therapy is particularly beneficial for circadian rhythm sleep disorders, insomnia, and sleep problems related to Alzheimer's disease and dementia. For insomnia specifically, researchers found that higher light intensity treatments showed larger effects. The analysis revealed that effects were smaller when examining only randomized controlled trials for circadian rhythm disorders, and studies with more female participants showed larger effects for dementia-related sleep problems. While the findings support light therapy as an effective intervention, the researchers noted indication of publication bias and emphasized that most effect sizes were in the small to medium range. This research is relevant to morning sunlight exposure as it demonstrates the broader therapeutic potential of light-based interventions for sleep regulation.

Neurodegenerative

[Light and Medicine].

Deutsche medizinische Wochenschrift (1946)Dec 2016

AI Summary

This research discusses the fundamental role of light in regulating biological functions through our internal body clocks. The study suggests that Earth's rotation has led to the development of biological clocks in all living organisms, which regulate bodily functions through 24-hour circadian rhythms and seasonal patterns. The researchers emphasize that these light-driven rhythmic patterns have significant impacts on both health and disease, affecting both diagnostic approaches and treatment strategies. Notably, the study indicates that bright light therapy has demonstrated therapeutic effectiveness, particularly for seasonal affective disorder, where it may be even more effective than certain antidepressant medications. This research provides foundational understanding of how light exposure influences our biological systems, though the abstract lacks specific details about study methodology, sample sizes, or duration of light exposure protocols.

Effects of Meditation and Yoga on Anxiety, Depression and Chronic Inflammation in Patients with Parkinson's Disease: A Randomized Clinical Trial.

AI Summary

Key Findings

Abstract

Authors

Related Protocol

AI Summary

Key Findings

Abstract

Authors

Related Protocol

Research Disclaimer